Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Benelux, Germany, the United Kingdom, and internationally. The company offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. It also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; and Epiguide, a patient-specific drill guide for the treatment of painful joints. In addition, the company offers µiFidelity system, a web-based IT platform for damage assessment, surgical pre-planning, and patient customization of implants and related surgical instruments; and Epioscopy, a damage assessment tool. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.